OMC
QTTB icon

Oasis Management Company’s Q32 Bio QTTB Stock Holding History

Oasis Management Company’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,556
Closed -$353K – 115
2022
Q4 		$353K Hold
15,556
– – 0.07% 78
2022
Q3 		$451K Hold
15,556
– – 0.08% 89
2022
Q2 		$552K Buy
+15,556
New +$531K 0.1% 83

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Oasis Management Company's QTTB Position: Q1 2023 in Review

Oasis Management Company sold out of Q32 Bio (QTTB) in Q1 2023, closing a stake of 15,556 shares — an estimated $353K sold.

Oasis Management Company first reported a position in QTTB in Q2 2022 and held it in 3 quarters. The position peaked at $552K in Q2 2022. 62 funds tracked by Wall St. Rank hold QTTB as of Q1 2023.

  • Oasis Management Company reported no remaining Q32 Bio position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 15,556 Q32 Bio shares in Q1 2023, an estimated $353K.
  • Oasis Management Company first reported a position in Q32 Bio in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's Q32 Bio position peaked at $552K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.